FEDERAL HEALTH POLICY STRATEGIES for KIDNEY CARE PARTNERS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
| Lobbyist | Covered position, as disclosed |
|---|---|
| COLIN ROSKEY | — |
Health Issues HCR
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
| Lobbyist | Covered position, as disclosed |
|---|---|
| COLIN ROSKEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.